Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials. Hilund-Carlsen PF, Revheim ME, Alavi A, Satyamurthy N, et al. J Alzheimers Dis 2022 Oct 17. pii: JAD220841. doi: 10.3233/JAD-220841.

Read + Share

Amedeo Smart

Independent Medical Education

Hilund-Carlsen PF, Revheim ME, Alavi A, Satyamurthy N, et al. Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials. J Alzheimers Dis 2022 Oct 17. pii: JAD220841. doi: 10.3233/JAD-220841.
PMID: 36278356